AzTrials
AzTrials

CancerNCT04533165

Virtual Exercise Program to Reduce Cancer Related Fatigue

A study testing Exercise in people with Cancer and Cancer-related Problem/Condition, run by University of Colorado, Denver at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The objective of this investigation is to establish the feasibility and initial effectiveness of a novel exercise program for rural cancer survivors in Colorado suffering from cancer related fatigue. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Cancer, Cancer-related Problem/Condition, Fatigue
What is being tested?
Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
19 participants
Where
1 siteUnited States
Study dates
11 Nov 2021to May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult (>= 18 years) cancer survivor.
  • A maximum age of 80 will be set as virtual exercise may become unsafe as individuals get older.
  • A cancer diagnosis of any type
  • CRF is a common symptom across cancer types and the current CRF reference chart was developed using data from patients with all cancer types.
  • Current report of moderate-to-severe fatigue (> 3 on a 0-10 scale, per NCCN definition31)
  • Live in rural Colorado and surrounding areas (> 1-hour commute to major front range city [Denver, Fort Collins, and Colorado Springs])
Show all 11Show fewer
  • This program attempts to target individuals in Colorado and surrounding areas with restricted access to fitness centers that may offer cancer specific services, most likely found in major front range cities. We have defined rural in terms of commute time to these cities, as it is the commute to these centers that restricts access.
  • Completed medical cancer treatment (chemotherapy and/or radiation) with curative intent within past 12 months or currently on treatment with no planned changes for the next 4 months (e.g. maintenance or palliative therapy).
  • No additional treatment planned for next 4 months.
  • These restrictions are made to ensure the validity of tracking changes with the established reference chart, which was developed using data from cancer survivors who had recently completed therapy or were on therapy14. It is unclear how fatigue response to exercise may change in survivors further out from treatment completion.
  • High-speed home internet and smartphone (or laptop with camera).

Who cannot join

  • Medical conditions that would impact the safety of, or participation in, an exercise program. This includes:
  • Orthopedic conditions such as advanced osteoarthritis, mobility-limiting amputations or chronic injuries, or mobility- limiting acute orthopedic injuries
  • Advanced rheumatoid arthritis
  • Widespread chronic pain conditions such as fibromyalgia
  • Significant balance impairment increasing the risk of falling
  • Pulmonary conditions such as chronic obstructive pulmonary disease, emphysema, interstitial lung disease, use of supplemental oxygen
  • Known cardiovascular disease, uncontrolled hypertension, or new cardiac event within the past 6 months.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Anschutz Health and Wellness

    Aurora, Colorado, 80045

Other trials in United States

About this study

Official title: Feasibility and Effectiveness of an Innovative Exercise Program to Reduce Fatigue in Rural Cancer Survivors

The objective of this investigation is to establish the feasibility and initial effectiveness of a novel exercise program for rural cancer survivors in Colorado suffering from cancer related fatigue. Participation in an exercise program has regularly been shown to reduce fatigue in cancer survivors, though in-person, supervised participation has a greater effect on fatigue than home-based programs with no supervision. Access to these supervised programs are limited in rural areas, restricting the ability of rural cancer survivors to experience the fatigue-reducing benefits of exercise. The proposed program will use information on improvements in fatigue from participants in the BfitBwell Cancer Exercise Program to monitor improvements in fatigue in rural cancer survivors performing a home exercise program and trigger a telehealth session with a cancer exercise specialist to adapt the exercise prescription when improvements are less than expected. The BfitBwell Program is an established exercise program at the Anschutz Health and Wellness Center which has worked with over 600 cancer survivors and is highly effective at reducing cancer related fatigue. The goal of the program is to replicate the effects of a successful supervised exercise program in rural cancer survivors who do not have access to this type of program. This investigation will recruit 20 rural cancer survivors experiencing fatigue and assess their ability to participate in the program, as well as how well the program improves their fatigue. Interviews will be conducted with participants after the program to determine how future versions of the program could be improved. The investigators anticipate that this program will be feasible and effective, providing preliminary data to pursue a large-scale clinical trial of the program following this project's completion.

Read the detailed description

The proposed exercise program utilizes a novel reference chart system to monitor cancer-related fatigue (CRF) and trigger necessary interventions. This reference chart has been developed from CRF data collected in 173 cancer survivors participating in the BfitBwell Program, a highly effective supervised exercise program pioneered at the University of Colorado. The reference chart estimates the continuous trajectory of fatigue improvement during the three-month program. The focus of this study is to extend the benefits of an effective, supervised exercise program to rural Coloradoans via a home exercise program supported by CRF monitoring and symptom-triggered telehealth sessions. Deviations from estimated improvements in CRF will trigger telehealth sessions with a cancer exercise specialist (CES) to adapt the exercise prescription, in real time, as in a supervised program. The intent is to replicate the effects of a supervised exercise program in cancer survivors in rural areas without access to such programs. The feasibility, effectiveness, and design of the program will be assessed with two specific aims.

Aim 1: Determine the feasibility and preliminary effectiveness of the proposed exercise program.

Objective 1a: Assess the enrollment rate of patients able and willing to participate in the program and the adherence of patients enrolled in the program to their prescribed exercise, CRF monitoring, and telehealth session participation.

Objective 1b: Assess the effect of the proposed program on CRF improvements in enrolled participants and compare this effect to that of the supervised BfitBwell exercise program.

Exploratory Objective 1: Assess the feasibility of the semi-continuous remote monitoring of fatigue (ecological momentary assessment) to better tailor the program to more acute changes in CRF.

Aim 2: Assess participant perspectives of barriers and facilitators to participation in the prescribed exercise and CRF monitoring.

Objective 2: Gather qualitative data on barriers and facilitators to participation from all participants enrolling in the program using semi-structured interviews.

This is an innovative program, being the first exercise intervention to implement real time adaptations for rural patients, with decisions anchored against a novel symptom monitoring system. Qualitative data will be collected to improve the next iteration of the program and to inform a future, large-scale clinical trial of program implementation in rural populations. The long-term goal is to develop a feasible and effective exercise program for rural cancer survivors which replicates the benefits of supervised exercise programs to which access may be restricted in rural settings.

This is a prospective, single-arm pilot intervention trial. It will collect objective data on the feasibility and effectiveness of the intervention, as well as qualitative data to inform how the intervention could be improved in future iterations. The exploratory aim will collect data on "in-the-moment" fatigue that could also inform novel future versions of the intervention.

This investigation will recruit adult cancer survivors treated at the University of Colorado Cancer Center (aged 18 years and over) who live in rural Colorado, have completed cancer treatment, and report moderate-to-severe CRF (> 3 on a 0-10 scale, per NCCN definition). Cancer type will be limited to the three types with the highest anticipated new cases in Colorado in 2020: breast, prostate, and lung. Only survivors who have completed medical treatment (chemotherapy and/or radiation), with curative intent, within the past 12 months, and have no additional treatment planned for the next four months, will be recruited. Rural participants will be defined as those who have greater than a 1-hour commute to the major front range cities (Denver, Fort Collins, and Colorado Springs). Participants must have home internet access and smartphones to allow participation in telehealth sessions and remote monitoring of exercise participation and fatigue. Participants with medical conditions that would impact the safety of, or participation in, an exercise program will be excluded. Twenty participants will be recruited in one year, with the goal of retaining at least 15 through the final assessment.

Participants will complete assessments (baseline and final) and exercise sessions virtually. The primary outcome measure will be the Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue) scale. Other assessment items will include measures of physical fitness and function. CRF will be assessed by questionnaires every two weeks, and semi-continuously with a smartphone application. The exercise program is 12 weeks long, and includes 2 mandatory virtual exercise sessions, and up to 5 triggered virtual exercise sessions. Participants will be mailed equipment to complete the study upon enrollment.

Being tested
Exercise
Keywords
Exercise, Telehealth, Cancer-related fatigue
Medical subject headings
Neoplasms, Fatigue, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ExerciseBehavioural

    12 week exercise prescription targeting 3 days of at least 30 min of aerobic exercise and 2 days of resistance exercise per week. Adapted to individual abilities, goals, and needs. Exercise intensity targets a 6-7 out of 10 on a 0-10 rate of perceived exertion scale.

Study groups in NCT04533165
Study groupRoleWhat they receive
Virtual exercise programExperimentalThis arm will receive the virtual exercise program.
Receives: Behavioral: Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue) at 12 weeks

    13-item instrument widely used to assess cancer related fatigue. Score range: 0-52. Lower scores indicate more fatigue.

    Measured: Baseline (week 0), 12 weeks

Secondary outcomes (26)
  1. Changes in Steps per day

    Average steps per day over a 7 day period, assessed with commercial fitness tracker

    Measured: Baseline (week 0), 12 weeks

  2. Changes in Average sleep time

    Average sleep time per day over a 7 day period, assessed with commercial fitness tracker

    Measured: Baseline (week 0), 12 weeks

  3. Changes in Single limb stance

    Time participant can stand on one leg, up to 30 s

    Measured: Baseline (week 0), 12 weeks

  4. Changes in Gait speed

    Gait speed over a 4 m distance, in m/s

    Measured: Baseline (week 0), 12 weeks

  5. Changes in Timed up and go

    Time (in s) to rise from a chair, walk 3 m, turn around, walk back to chair, and sit down

    Measured: Baseline (week 0), 12 weeks

  6. Changes in 30 s Sit-to-Stand

    Number of times one can stand and sit from a chair in 30 s

    Measured: Baseline (week 0), 12 weeks

  7. Changes Tecumseh Step Test

    Participants steps on and off an 8" step at a rate of 24 steps/min for 3 min. Heart rate is recorded at 30 s and 1 min after completion.

    Measured: Baseline (week 0), 12 weeks

  8. Changes in Functional Assessment of Cancer Therapy-General form (FACT-G) at 12 weeks

    Common questionnaire assessing health related quality of life in cancer survivors, range 0-108, higher scores indicate better quality of life

    Measured: Baseline (week 0), 12 weeks

  9. Changes in Functional Assessment of Cancer Therapy-General form (FACT-G) at 6 month

    Common questionnaire assessing health related quality of life in cancer survivors, range 0-108, higher scores indicate better quality of life

    Measured: Baseline (week 0), 6 months

  10. Changes in Functional Assessment of Cancer Therapy-General form (FACT-G) at 9 months

    Common questionnaire assessing health related quality of life in cancer survivors, range 0-108, higher scores indicate better quality of life

    Measured: Baseline (week 0), 9 months

  11. Changes in Functional Assessment of Cancer Therapy-General form (FACT-G) at 15 months

    Common questionnaire assessing health related quality of life in cancer survivors, range 0-108, higher scores indicate better quality of life

    Measured: Baseline (week 0), 15 months

  12. Changes in Multidimensional Fatigue Inventory (MFI) at 12 weeks

    Questionnaire with multiple subscales of fatigue identified. Score range: 0-100, higher scores indicate increased fatigue

    Measured: Baseline (week 0), 12 weeks

  13. Changes in Multidimensional Fatigue Inventory (MFI) at 6 months

    Questionnaire with multiple subscales of fatigue identified. Score range: 0-100, higher scores indicate increased fatigue

    Measured: Baseline (week 0), 6 months

  14. Changes in Multidimensional Fatigue Inventory (MFI) at 9 months

    Questionnaire with multiple subscales of fatigue identified. Score range: 0-100, higher scores indicate increased fatigue

    Measured: Baseline (week 0), 9 months

  15. Changes in Multidimensional Fatigue Inventory (MFI) at 15 months

    Questionnaire with multiple subscales of fatigue identified. Score range: 0-100, higher scores indicate increased fatigue

    Measured: Baseline (week 0), 15 months

  16. Changes in Hospital Anxiety and Depression Scale (HADS) at 12 weeks

    Questionnaire to assess anxiety and depression in populations with medical conditions. Score range: 0-42, higher scores indicate presence of anxiety and depression

    Measured: Baseline (week 0), 12 weeks

  17. Changes in Hospital Anxiety and Depression Scale (HADS) at 6 months

    Questionnaire to assess anxiety and depression in populations with medical conditions. Score range: 0-42, higher scores indicate presence of anxiety and depression

    Measured: Baseline (week 0), 6 months

  18. Changes in Hospital Anxiety and Depression Scale (HADS) at 9 months

    Questionnaire to assess anxiety and depression in populations with medical conditions. Score range: 0-42, higher scores indicate presence of anxiety and depression

    Measured: Baseline (week 0), 9 months

  19. Changes in Hospital Anxiety and Depression Scale (HADS) at 15 months

    Questionnaire to assess anxiety and depression in populations with medical conditions. Score range: 0-42, higher scores indicate presence of anxiety and depression

    Measured: Baseline (week 0), 15 months

  20. Change in Godin Leisure-Time Physical Activity Questionnaire (GLTPAQ) at 12 weeks

    Self-report of time spent in light, moderate, and vigorous physical activity in minutes.

    Measured: Baseline (week 0), 12 weeks

  21. Change in Godin Leisure-Time Physical Activity Questionnaire (GLTPAQ) at 6 months

    Self-report of time spent in light, moderate, and vigorous physical activity in minutes.

    Measured: Baseline (week 0), 6 months

  22. Change in Godin Leisure-Time Physical Activity Questionnaire (GLTPAQ) at 9 months

    Self-report of time spent in light, moderate, and vigorous physical activity in minutes.

    Measured: Baseline (week 0), 9 months

  23. Change in Godin Leisure-Time Physical Activity Questionnaire (GLTPAQ) at 15 months

    Self-report of time spent in light, moderate, and vigorous physical activity in minutes.

    Measured: Baseline (week 0), 15 months

  24. Change in Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue) at 6 months

    13-item instrument widely used to assess cancer related fatigue. Score range: 0-52. Lower scores indicate more fatigue.

    Measured: Baseline (week 0), 6 months

  25. Change in Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue) at 9 months

    13-item instrument widely used to assess cancer related fatigue. Score range: 0-52. Lower scores indicate more fatigue.

    Measured: Baseline (week 0), 9 months

  26. Change in Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue) at 15 months

    13-item instrument widely used to assess cancer related fatigue. Score range: 0-52. Lower scores indicate more fatigue.

    Measured: Baseline (week 0), 15 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Aug 2020
  2. Study start11 Nov 2021
  3. Primary completion12 Apr 2023
  4. Study completionMay 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Model description
Prospective, single-arm pilot interventional trial
Masking
None (open label)
Enrolment
19 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04533165
Sponsor's protocol ID
20-2015.cc
Status last verified
Jul 2026
First submitted
6 Aug 2020
Last updated
13 Jul 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Marker RJ, Kittelson AJ, Scorsone JJ, Moran IA, Quindry JC, Leach HJ. A Novel Telehealth Exercise Program Designed for Rural Survivors of Cancer With Cancer-Related Fatigue: Single-Arm Feasibility Trial. JMIR Cancer. 2025 Jan 10;11:e59478. doi: 10.2196/59478.

    PubMed 39793972

Questions about this trial

What is this clinical trial studying?

A study testing Exercise in people with Cancer and Cancer-related Problem/Condition, run by University of Colorado, Denver at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 13 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue) at 12 weeks (time frame: Baseline (week 0), 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04533165, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT04533165 | AzTrials